91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Exosome Service Market Research Report 2024

Global Exosome Service Market Research Report 2024

Publication ID: 
PB505248013
Publication Date: 
May 30, 2024
Pages: 
103
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

IT Services [2]
Computing & Electronics [3]
Description: 

Exosome service refers to the provision of services related to exosomes, which are small extracellular vesicles that play a crucial role in intercellular communication. Exosomes are released by various cell types and contain proteins, lipids, and nucleic acids that can be transferred to recipient cells, influencing their function and behavior. Exosomes are small (~40鈥�150 nm) extracellular vesicles (EVs) released from all cell types and found in body fluids and cell culture supernatants. Exosomes are generated by fusion of a specialized endosome, the multivesicular body (MVB), with the plasma membrane. Exosomes have been proposed to provide means for intercellular exchange of macromolecules, allowing the transfer of proteins, lipids, mRNA and miRNA, contributing to intercellular communication in relevant biological processes, including apoptosis, antigen presentation, angiogenesis, inflammation, and coagulation. Exosomes represent a promising new frontier in drug delivery as they are non-toxic and non-immunogenic nature, and readily programmable to carry biomolecular cargoes such as nucleotides and proteins that can serve as biotherapeutics for the treatment of diseases.
Exosome services may include isolation and purification of exosomes from different biological samples, characterization of exosomes using various techniques such as electron microscopy, flow cytometry, and proteomic analysis, as well as functional studies to understand their role in specific biological processes or diseases. Additionally, exosome services may also involve exosome-based therapies, where exosomes are used as therapeutic agents for drug delivery or regenerative medicine purposes.
The global Exosome Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Exosome Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Exosome Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Exosome Service in Medicine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Exosome Service include LipExoGen Biotech, Creative Biostructure, Immunostep Biotech, AMSBIO, Frontage Labs, EVerZom, System Biosicences (SBI), Exosome Diagnostics and Creative Bioarray, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Service.
Report Scope
The Exosome Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Exosome Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LipExoGen Biotech
Creative Biostructure
Immunostep Biotech
AMSBIO
Frontage Labs
EVerZom
System Biosicences (SBI)
Exosome Diagnostics
Creative Bioarray
Exosomics
Creative Proteomics
RoosterBio
Clara Biotech
Luminous BioSciences
Capital Biosciences
Anazao
Alpha Nano Tech
NCELL
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology
Segment by Type
Exosome Isolation
Exosome Identification
Exosome Analysis
Other
Segment by Application
Medicine
Biological
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Exosome Isolation
1.2.3 Exosome Identification
1.2.4 Exosome Analysis
1.2.5 Other
1.3 Market by Application
1.3.1 Global Exosome Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medicine
1.3.3 Biological
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Service Market Perspective (2019-2030)
2.2 Exosome Service Growth Trends by Region
2.2.1 Global Exosome Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Exosome Service Historic Market Size by Region (2019-2024)
2.2.3 Exosome Service Forecasted Market Size by Region (2025-2030)
2.3 Exosome Service Market Dynamics
2.3.1 Exosome Service Industry Trends
2.3.2 Exosome Service Market Drivers
2.3.3 Exosome Service Market Challenges
2.3.4 Exosome Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Service Players by Revenue
3.1.1 Global Top Exosome Service Players by Revenue (2019-2024)
3.1.2 Global Exosome Service Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Service Revenue
3.4 Global Exosome Service Market Concentration Ratio
3.4.1 Global Exosome Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Service Revenue in 2023
3.5 Exosome Service Key Players Head office and Area Served
3.6 Key Players Exosome Service Product Solution and Service
3.7 Date of Enter into Exosome Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Service Breakdown Data by Type
4.1 Global Exosome Service Historic Market Size by Type (2019-2024)
4.2 Global Exosome Service Forecasted Market Size by Type (2025-2030)
5 Exosome Service Breakdown Data by Application
5.1 Global Exosome Service Historic Market Size by Application (2019-2024)
5.2 Global Exosome Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Exosome Service Market Size (2019-2030)
6.2 North America Exosome Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Exosome Service Market Size by Country (2019-2024)
6.4 North America Exosome Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Service Market Size (2019-2030)
7.2 Europe Exosome Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Exosome Service Market Size by Country (2019-2024)
7.4 Europe Exosome Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Service Market Size (2019-2030)
8.2 Asia-Pacific Exosome Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Exosome Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Exosome Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Service Market Size (2019-2030)
9.2 Latin America Exosome Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Exosome Service Market Size by Country (2019-2024)
9.4 Latin America Exosome Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Service Market Size (2019-2030)
10.2 Middle East & Africa Exosome Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Exosome Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Exosome Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LipExoGen Biotech
11.1.1 LipExoGen Biotech Company Detail
11.1.2 LipExoGen Biotech Business Overview
11.1.3 LipExoGen Biotech Exosome Service Introduction
11.1.4 LipExoGen Biotech Revenue in Exosome Service Business (2019-2024)
11.1.5 LipExoGen Biotech Recent Development
11.2 Creative Biostructure
11.2.1 Creative Biostructure Company Detail
11.2.2 Creative Biostructure Business Overview
11.2.3 Creative Biostructure Exosome Service Introduction
11.2.4 Creative Biostructure Revenue in Exosome Service Business (2019-2024)
11.2.5 Creative Biostructure Recent Development
11.3 Immunostep Biotech
11.3.1 Immunostep Biotech Company Detail
11.3.2 Immunostep Biotech Business Overview
11.3.3 Immunostep Biotech Exosome Service Introduction
11.3.4 Immunostep Biotech Revenue in Exosome Service Business (2019-2024)
11.3.5 Immunostep Biotech Recent Development
11.4 AMSBIO
11.4.1 AMSBIO Company Detail
11.4.2 AMSBIO Business Overview
11.4.3 AMSBIO Exosome Service Introduction
11.4.4 AMSBIO Revenue in Exosome Service Business (2019-2024)
11.4.5 AMSBIO Recent Development
11.5 Frontage Labs
11.5.1 Frontage Labs Company Detail
11.5.2 Frontage Labs Business Overview
11.5.3 Frontage Labs Exosome Service Introduction
11.5.4 Frontage Labs Revenue in Exosome Service Business (2019-2024)
11.5.5 Frontage Labs Recent Development
11.6 EVerZom
11.6.1 EVerZom Company Detail
11.6.2 EVerZom Business Overview
11.6.3 EVerZom Exosome Service Introduction
11.6.4 EVerZom Revenue in Exosome Service Business (2019-2024)
11.6.5 EVerZom Recent Development
11.7 System Biosicences (SBI)
11.7.1 System Biosicences (SBI) Company Detail
11.7.2 System Biosicences (SBI) Business Overview
11.7.3 System Biosicences (SBI) Exosome Service Introduction
11.7.4 System Biosicences (SBI) Revenue in Exosome Service Business (2019-2024)
11.7.5 System Biosicences (SBI) Recent Development
11.8 Exosome Diagnostics
11.8.1 Exosome Diagnostics Company Detail
11.8.2 Exosome Diagnostics Business Overview
11.8.3 Exosome Diagnostics Exosome Service Introduction
11.8.4 Exosome Diagnostics Revenue in Exosome Service Business (2019-2024)
11.8.5 Exosome Diagnostics Recent Development
11.9 Creative Bioarray
11.9.1 Creative Bioarray Company Detail
11.9.2 Creative Bioarray Business Overview
11.9.3 Creative Bioarray Exosome Service Introduction
11.9.4 Creative Bioarray Revenue in Exosome Service Business (2019-2024)
11.9.5 Creative Bioarray Recent Development
11.10 Exosomics
11.10.1 Exosomics Company Detail
11.10.2 Exosomics Business Overview
11.10.3 Exosomics Exosome Service Introduction
11.10.4 Exosomics Revenue in Exosome Service Business (2019-2024)
11.10.5 Exosomics Recent Development
11.11 Creative Proteomics
11.11.1 Creative Proteomics Company Detail
11.11.2 Creative Proteomics Business Overview
11.11.3 Creative Proteomics Exosome Service Introduction
11.11.4 Creative Proteomics Revenue in Exosome Service Business (2019-2024)
11.11.5 Creative Proteomics Recent Development
11.12 RoosterBio
11.12.1 RoosterBio Company Detail
11.12.2 RoosterBio Business Overview
11.12.3 RoosterBio Exosome Service Introduction
11.12.4 RoosterBio Revenue in Exosome Service Business (2019-2024)
11.12.5 RoosterBio Recent Development
11.13 Clara Biotech
11.13.1 Clara Biotech Company Detail
11.13.2 Clara Biotech Business Overview
11.13.3 Clara Biotech Exosome Service Introduction
11.13.4 Clara Biotech Revenue in Exosome Service Business (2019-2024)
11.13.5 Clara Biotech Recent Development
11.14 Luminous BioSciences
11.14.1 Luminous BioSciences Company Detail
11.14.2 Luminous BioSciences Business Overview
11.14.3 Luminous BioSciences Exosome Service Introduction
11.14.4 Luminous BioSciences Revenue in Exosome Service Business (2019-2024)
11.14.5 Luminous BioSciences Recent Development
11.15 Capital Biosciences
11.15.1 Capital Biosciences Company Detail
11.15.2 Capital Biosciences Business Overview
11.15.3 Capital Biosciences Exosome Service Introduction
11.15.4 Capital Biosciences Revenue in Exosome Service Business (2019-2024)
11.15.5 Capital Biosciences Recent Development
11.16 Anazao
11.16.1 Anazao Company Detail
11.16.2 Anazao Business Overview
11.16.3 Anazao Exosome Service Introduction
11.16.4 Anazao Revenue in Exosome Service Business (2019-2024)
11.16.5 Anazao Recent Development
11.17 Alpha Nano Tech
11.17.1 Alpha Nano Tech Company Detail
11.17.2 Alpha Nano Tech Business Overview
11.17.3 Alpha Nano Tech Exosome Service Introduction
11.17.4 Alpha Nano Tech Revenue in Exosome Service Business (2019-2024)
11.17.5 Alpha Nano Tech Recent Development
11.18 NCELL
11.18.1 NCELL Company Detail
11.18.2 NCELL Business Overview
11.18.3 NCELL Exosome Service Introduction
11.18.4 NCELL Revenue in Exosome Service Business (2019-2024)
11.18.5 NCELL Recent Development
11.19 Wayen Biotechnologies (Shanghai)
11.19.1 Wayen Biotechnologies (Shanghai) Company Detail
11.19.2 Wayen Biotechnologies (Shanghai) Business Overview
11.19.3 Wayen Biotechnologies (Shanghai) Exosome Service Introduction
11.19.4 Wayen Biotechnologies (Shanghai) Revenue in Exosome Service Business (2019-2024)
11.19.5 Wayen Biotechnologies (Shanghai) Recent Development
11.20 Shanghai Yanjiang Biotechnology
11.20.1 Shanghai Yanjiang Biotechnology Company Detail
11.20.2 Shanghai Yanjiang Biotechnology Business Overview
11.20.3 Shanghai Yanjiang Biotechnology Exosome Service Introduction
11.20.4 Shanghai Yanjiang Biotechnology Revenue in Exosome Service Business (2019-2024)
11.20.5 Shanghai Yanjiang Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned: 

LipExoGen Biotech
Creative Biostructure
Immunostep Biotech
AMSBIO
Frontage Labs
EVerZom
System Biosicences (SBI)
Exosome Diagnostics
Creative Bioarray
Exosomics
Creative Proteomics
RoosterBio
Clara Biotech
Luminous BioSciences
Capital Biosciences
Anazao
Alpha Nano Tech
NCELL
Wayen Biotechnologies (Shanghai)
Shanghai Yanjiang Biotechnology

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-exosome-service-market-research-report-2024

Links
[1] /countries/global[2] /it-services[3] /computing-electronics